Developer of peptides for intermediates and finished drugs. The Company is engaged in pharmaceutical research and development of peptides and peptide containing drugs for hepatitis C virus, cystic fibrosis, prostate cancer, myeloma, soft tissue sarcoma, leukemia, rare disease and others. Read More